Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

262
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

163
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
163
EDTA: Direct, Back-, and Displacement Titration01:30

EDTA: Direct, Back-, and Displacement Titration

5.2K
The EDTA titration types for metal ion analysis include direct titration, back-titration, and replacement titration.
Direct titration involves buffering the metal ion solution to the desired pH and directly titrating with standard EDTA until the endpoint. The optimum pH ensures a large conditional formation constant of metal−EDTA and visibility of the free indicator color in the solution. In addition, auxiliary complexing reagents are used to prevent the precipitation of metal hydroxides...
5.2K
EDTA: Indirect and Alkalimetric Titration01:23

EDTA: Indirect and Alkalimetric Titration

1.7K
Unlike direct titration, back-titration, and displacement titration, indirect titration is an EDTA titration method for quantifying anions. In the indirect titration method, anions are precipitated as their insoluble salts with excess metal ions. The filtrate containing the excess metal ions is directly titrated with standard EDTA until the endpoint is achieved. Another approach involves extracting the metal ion and back-titrating with standard EDTA to obtain the endpoint. In this way, the...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assay of Efanesoctocog Alfa in 200 Centres: Data From Collaborative NEQAS BC (United Kingdom) and ECAT (Netherlands) Exercise Autumn 2024.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

UKNEQAS Blood Coagulation Factor Nine (FIX) Gene Therapy Supplementary Exercise 2025.

Haemophilia : the official journal of the World Federation of Hemophilia·2025
Same author

Cold Stored Platelets: A Solution for Platelet Aggregation External Quality Assessment/Proficiency Testing.

International journal of laboratory hematology·2025
Same author

Comparison of Thrombophilia Assay Results for the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Plasma Standard from Different External Quality Assessment Providers-for the External Quality Assurance in Thrombosis and Haemostasis Group.

Seminars in thrombosis and hemostasis·2024
Same author

Internal Quality Control in Hemostasis Assays.

Seminars in thrombosis and hemostasis·2023
Same author

Laboratory international normalized ratios determined with commercial thromboplastins in >450 centers before and after the establishment of the International Standard for human thromboplastin-rTF 16: data from United Kingdom National External Quality Assessment Scheme for Blood Coagulation.

Journal of thrombosis and haemostasis : JTH·2023

Related Experiment Video

Updated: Jan 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.3K

Laboratory Testing of Direct Oral Anticoagulants.

Christopher Reilly-Stitt1

  • 1UK NEQAS (Blood Coagulation), Sheffield, UK. christopher.reilly-stitt@nhs.net.

Handbook of Experimental Pharmacology
|December 15, 2025
PubMed
Summary

Direct oral anticoagulants (DOACs) offer convenience but require laboratory testing in specific situations. Assays are crucial for accuracy, quality control, and managing potential interferences with other hemostasis tests.

Keywords:
Anti-Xa assayAnticoagulant therapyAtrial fibrillationDilute thrombin time (DTT)Direct oral anticoagulants (DOACs)Direct thrombin inhibitorEcarin clotting time (ECT)External Quality Assessment (EQA)Factor Xa inhibitorsInternal Quality Control (IQC)LC-MS/MSVenous thromboembolism (VTE)

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K

Related Experiment Videos

Last Updated: Jan 8, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.3K
In Vitro Thrombosis Test for Ventricular Assist Devices
09:15

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

1.1K
Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow
09:41

Hemocompatibility Testing of Blood-Contacting Implants in a Flow Loop Model Mimicking Human Blood Flow

Published on: March 5, 2020

10.0K

Area of Science:

  • Pharmacology and Clinical Laboratory Science
  • Hemostasis and Thrombosis
  • Drug Monitoring

Background:

  • Direct oral anticoagulants (DOACs), including dabigatran and factor Xa inhibitors, have transformed anticoagulant therapy.
  • DOACs offer advantages over traditional anticoagulants like warfarin, such as predictable pharmacokinetics and minimal drug/food interactions.
  • Routine laboratory monitoring is generally not required for DOACs, simplifying patient management.

Purpose of the Study:

  • To review the pharmacology, clinical applications, and laboratory evaluation of DOACs.
  • To outline available assays for DOAC quantification and discuss their principles.
  • To highlight the importance of laboratory assessment in specific clinical scenarios and address assay interferences.

Main Methods:

  • Review of literature on DOAC pharmacology, clinical use, and laboratory assays.
  • Discussion of analytical principles for quantification methods like LC-MS/MS, chromogenic anti-Xa, and ecarin-based assays.
  • Examination of the impact of DOACs on routine coagulation tests and other hemostasis assays, including interference mitigation strategies.

Main Results:

  • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for DOAC quantification, with chromogenic anti-Xa and dilute thrombin time (DTT) assays being common alternatives.
  • DOACs have variable effects on routine coagulation tests (PT, APTT, TT), necessitating drug-specific calibrators and validation.
  • DOACs can interfere with other hemostasis assays, but activated charcoal-based reagents can neutralize this interference.

Conclusions:

  • Despite their advantages, laboratory testing of DOACs remains critical in specific clinical situations like bleeding, thrombosis, or emergency surgery.
  • Quality assurance (IQC and EQA) is essential for accurate and reproducible DOAC assay results, adhering to ISO 15189:2022 standards.
  • DOACs have largely replaced warfarin for conditions like atrial fibrillation and venous thromboembolism, but laboratory monitoring is key for safe and effective patient care.